Literature DB >> 19574885

Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.

Lawrance Chung1, Sean K Lau, Zhong Jiang, Sofia Loera, Victoria Bedel, Jianling Ji, Lawrence M Weiss, Peiguo G Chu.   

Abstract

Dedifferentiated liposarcoma (DDL), occurring in up to 10% of well differentiated liposarcoma cases, has similar histologic features to that of undifferentiated high-grade pleomorphic sarcoma (UHGPS); the former develops in a background of atypical lipomatous tumors/well differentiated liposarcoma, whereas the latter shows no specific line of differentiation. The retroperitoneum and thigh represent the most common anatomic locations for both the sarcomas. Despite their morphologic similarity, the issue of whether these 2 sarcomas share overlapping immunohistochemical and molecular features has not been well studied. We examined the expression of the lipogenic tumor-related markers peroxisome proliferator-activated receptor gamma (PPAR-gamma), CDK4, and MDM2 in 15 cases of DDL and 45 cases of retroperitoneal/thigh UHGPS. Patients with DDL ranged from 31 to 82 years (mean 63 y) with a male:female ratio of 5:3. Patients with UHGPS ranged from 14 to 80 years (mean 52 y) with a male:female ratio of 3:2. All 15 DDLs expressed CDK4 and MDM2 (100%), and 8 of 15 cases expressed PPAR-gamma (53%). Twenty-three of 45 (51%) UHGPS expressed at least 1 of these 3 markers. We also studied MDM2 and CDK4 gene amplification by fluorescence in situ hybridization in 28 immunohistochemically positive cases, including 5 DDLs and 23 UHGPSs. All 5 cases of DDL showed MDM2 and/or CDK4 amplification (100%), whereas 6 of 45 UHGPSs showed MDM2 and/or CDK4 amplification (13%). Our results demonstrate that (1) the lipogenic tumor markers CDK4 and MDM2 can be used as surrogate immunohistochemical markers for the diagnosis of malignant lipomatous tumors with high sensitivity; (2) approximately 26% of retroperitoneal/thigh UHGPS cases that were positive for PPAR-gamma, CDK4, or MDM2 by immunohistochemistry showed characteristic CDK4 and MDM2 gene amplification, suggesting that a subset of UHGPS cases represent DDL despite lacking histologic evidence of lipoblasts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19574885     DOI: 10.1097/PAS.0b013e3181accb01

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.

Authors:  Anne M Mills; Andrew H Beck; Kelli D Montgomery; Shirley X Zhu; Inigo Espinosa; Cheng-Han Lee; Subbaya Subramanian; Christopher D Fletcher; Matt van de Rijn; Robert B West
Journal:  Am J Surg Pathol       Date:  2011-04       Impact factor: 6.394

2.  Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH.

Authors:  Hatem Q Al-Maghraby; Walid E Khalbuss; Uma N M Rao; Kathleen Cieply; Sanja Dacic; Sara E Monaco
Journal:  Cytojournal       Date:  2010-04-06       Impact factor: 2.091

3.  Recurrent dedifferentiated paratesticular liposarcoma with synchronous renal cell carcinoma and prostate cancer.

Authors:  D Coyle; R A Flaherty; B D Kelly; S O Hynes; F Colesky; M R Quinlan; M O Corcoran; E Rogers
Journal:  Curr Urol       Date:  2013-02-08

4.  Primary duodenal dedifferentiated liposarcoma: A case report and literature review.

Authors:  Nah Ihm Kim; Ji Shin Lee; Chan Choi; Jong Hee Nam; Yoo Duk Choi; Hee Joon Kim; Sung Sun Kim
Journal:  World J Clin Cases       Date:  2022-02-26       Impact factor: 1.337

5.  A Case of Primary Duodenal Liposarcoma.

Authors:  Zachary Whitham; Aaron Blackham; Victoria Loven
Journal:  Case Rep Oncol       Date:  2020-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.